Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Gamma-secretase
    (2)
  • Antibiotic
    (1)
  • Beta Amyloid
    (1)
  • DNA/RNA Synthesis
    (1)
  • Influenza Virus
    (1)
  • TNF
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

ro7

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
HRO761
Werner syndrome RecQ helicase-IN-1, HRO-761
T721072869954-34-5
HRO761 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Hot
RO7185876
T397022226038-71-5In house
RO7185876 is a selective gamma secretase modulator, which can be used in the study of Alzheimer's disease.
  • $293 TargetMol
In Stock
Size
QTY
RO7567132
RO 7567132, RG6221, RG 6221, FAP-LTBR, FAPLTBR
T9901A-748
RO7567132 (FAP-LTBR) is a novel bispecific antibody that binds and agonizes LTBR bivalently while binds and antagonizes FAP monovalently, thereby limiting the activation of LTBR to the tumor microenvironment, inducing the formation of local tertiary lymphoid structures (TLS), and reducing systemic toxicity. Its mouse alternative can inhibit breast cancer growth, and the effect is better when combined with atezolizumab. In the mouse colorectal cancer model, it can also enhance immune cell infiltration and TLS-like structure formation.
  • Inquiry Price
Size
QTY
(9R)-RO7185876
T2043582226077-86-5
(9R)-RO7185876 (Compound example 16) is a γ-secretase inhibitor. It reduces the secretion of Αβ42. This compound can be employed in the research of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, multi-infarct dementia, senile dementia, or Down syndrome.
  • Inquiry Price
10-14 weeks
Size
QTY
RO7122290
RO7122290 (Anti-4-1BB & FAP), RO7122290
T9901A-789
RO7122290 is a bispecific antibody-like fusion protein composed of a trimeric ligand for the T-cell co-stimulatory receptor 4-1BB (CD137) and an antigen-binding fragment (Fab) targeting the tumor-associated protein fibroblast activation protein (FAP), with potential immunomodulatory and antitumor activities. It shows promise in the treatment of advanced solid tumors. Molecular weight: 177.78 KD.
  • Inquiry Price
Size
QTY
RO7196472
TP28652097285-98-6
RO7196472 is a potent macrocyclic peptide antibiotic that selectively inhibits the activity of Acinetobacter strains. It targets the lipopolysaccharide (LPS) binding site on the inner membrane's LptB2FG complex, inhibiting lipopolysaccharide transport and thereby suppressing the activity of Acinetobacter strains.
  • Inquiry Price
Size
QTY
RO-7
T127431370241-45-4
RO-7 is a next-generation polymerase (PA) endonuclease inhibitor of influenza A and B viruses.
  • $1,970
8-10 weeks
Size
QTY
Ro 7-0213
Ro-7-0213
T34365123723-78-4
RO 7-0213 is a novel benzodiazepine (RO7-0213) containing a fully positive quaternary ammonium component.
  • Inquiry Price
6-8 weeks
Size
QTY
Ro 7-9767
Ro7-9767, Ro-7-9767
T3436621247-74-5
Ro 7-9767 is a biochemical.
  • Inquiry Price
3-6 months
Size
QTY